Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 22:12:672026.
doi: 10.3389/fmicb.2021.672026. eCollection 2021.

Acute Infection of Viral Pathogens and Their Innate Immune Escape

Affiliations
Review

Acute Infection of Viral Pathogens and Their Innate Immune Escape

Kul Raj Rai et al. Front Microbiol. .

Abstract

Viral infections can cause rampant disease in human beings, ranging from mild to acute, that can often be fatal unless resolved. An acute viral infection is characterized by sudden or rapid onset of disease, which can be resolved quickly by robust innate immune responses exerted by the host or, instead, may kill the host. Immediately after viral infection, elements of innate immunity, such as physical barriers, various phagocytic cells, group of cytokines, interferons (IFNs), and IFN-stimulated genes, provide the first line of defense for viral clearance. Innate immunity not only plays a critical role in rapid viral clearance but can also lead to disease progression through immune-mediated host tissue injury. Although elements of antiviral innate immunity are armed to counter the viral invasion, viruses have evolved various strategies to escape host immune surveillance to establish successful infections. Understanding complex mechanisms underlying the interaction between viruses and host's innate immune system would help develop rational treatment strategies for acute viral infectious diseases. In this review, we discuss the pathogenesis of acute infections caused by viral pathogens and highlight broad immune escape strategies exhibited by viruses.

Keywords: acute infection; innate immune escape; innate immunity; non-structural protein; viral pathogens.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
General overview of intracellular innate immune signaling and some representative viral immune escape mechanisms. Sensing virus by PRRs initiates innate immune signaling through the hierarchical activation of PRRs family-specific adaptor proteins (TRIF, MAVS, STING, MYD88, and so forth) to activate transcriptional factors, such as IRF3/5/7, NF-kB, and others. Activated transcriptional factors translocate into nucleus and induce robust expression of IFNs. Secreted IFNs bind to their respective receptors and activate JAK-STAT signaling and form a transcriptional factor called ISGF3. ISGF3, then, translocates into nucleus to induce expression of numerous antiviral effectors (ISGs) to impede viral infection. Although antiviral innate immunity consists of well-equipped arsenals to impede viral infection and invasion, viruses circumvent or escape from these antiviral arsenals to establish successful infection through several mechanisms. Of these escape mechanisms, viral components inhibit innate immune signaling by diversified tactics, such as interacting directly or indirectly with crucial innate elements, targeting and cleaving adaptor proteins involved in innate immune signaling or interference of IFN signaling, degradation of JAK/STAT components, and so forth. Some representative viral immune escape tactics are shown in the Figure 1.

Similar articles

Cited by

References

    1. Abe T., Kaname Y., Hamamoto I., Tsuda Y., Wen X., Taguwa S., et al. (2007). Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines. J. Virol. 81 8953–8966. 10.1128/jvi.00649-07 - DOI - PMC - PubMed
    1. Acharya D., Liu G., Gack M. U. (2020). Dysregulation of type I interferon responses in COVID-19. Nat. Rev. Immunol. 20 397–398. 10.1038/s41577-020-0346-x - DOI - PMC - PubMed
    1. Akhtar L. N., Benveniste E. N. (2011). Viral exploitation of host SOCS protein functions. J. Virol. 85 1912–1921. 10.1128/jvi.01857-10 - DOI - PMC - PubMed
    1. Ascenzi P., Bocedi A., Heptonstall J., Capobianchi M. R., Di Caro A., Mastrangelo E., et al. (2008). Ebolavirus and Marburgvirus: insight the Filoviridae family. Mol. Aspects Med. 29 151–185. 10.1016/j.mam.2007.09.005 - DOI - PubMed
    1. Basler C. F., Mikulasova A., Martinez-Sobrido L., Paragas J., Mühlberger E., Bray M., et al. (2003). The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 77 7945–7956. 10.1128/JVI.77.14.7945-7956.2003 - DOI - PMC - PubMed

LinkOut - more resources